Commercial Models Shifting As Pharma Mulls Digital-First Launches
Executive Summary
Pharma is assessing digital-first launch strategies amid COVID-19 while a resizing of sales forces and the emergence of "digital orchestrators" may also be in store, the co-founder of healthcare solutions provider Indegene tells Scrip.
You may also be interested in...
India Compliance Shifts: Pharma’s Marketing Stack Has Big Opportunities For Health-Tech
Pharma may need to reorient its sales and marketing approach in India amid tighter regulatory scrutiny and growing digital adoption by physicians, opening up new opportunities for digital health startups to innovate across the commercialization value chain, indicates a leading venture capital firm.
Amgen, Sun Execs On Driving Brand Launch Success Even As 'Punches' Land
Senior executives from Amgen and Sun Pharma discuss strategies to get brand launches right amid changing market dynamics. Over 40% of drug launches are currently estimated to fall short of their two-year targets.
Boehringer Will Go 'Wide, Broad, Fast, Strong' If Jardiance Hits CKD Bullseye
Data is the new gold and Timmo Rousku Andersen, Boehringer Ingelheim’s corporate senior vice-president, head of global regions, outlines in an interview the German group's efforts to shape go-to-market models driven by data and insights. He also touches on digital therapeutics and how the firm’s R&D engine is pursuing deeper insights into interconnected disorders.